CMLCX
Price
$58.43
Change
+$0.42 (+0.72%)
Updated
Jun 26 closing price
Net Assets
106.24B
RMEBX
Price
$58.60
Change
+$0.43 (+0.74%)
Updated
Jun 26 closing price
Net Assets
107B
Interact to see
Advertisement

CMLCX vs RMEBX

Header iconCMLCX vs RMEBX Comparison
Open Charts CMLCX vs RMEBXBanner chart's image
American Funds American Mutual 529C
Price$58.43
Change+$0.42 (+0.72%)
VolumeN/A
Net Assets106.24B
American Funds American Mutual R2E
Price$58.60
Change+$0.43 (+0.74%)
VolumeN/A
Net Assets107B
CMLCX vs RMEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CMLCX vs. RMEBX commentary
Jun 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CMLCX is a Buy and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX (107B) and CMLCX (106B) have equal amount of cash in the bank . RMEBX pays higher dividends than CMLCX: RMEBX (1.16) vs CMLCX (0.86). CMLCX was incepted earlier than RMEBX: CMLCX (23 years) vs RMEBX (11 years). CMLCX (1.36) is less costly to investors than RMEBX (1.07). CMLCX (31.00) and RMEBX (31.00) have comparable annual turnover. CMLCX (250) and RMEBX (250) have matching initial minimum investment requirements. RMEBX (9.50) and CMLCX (9.14) have marching annual gain over last year. RMEBX (62.71) and CMLCX (60.18) have equivalent 5 years return.
CMLCXRMEBXCMLCX / RMEBX
Total Expense Ratio1.361.07127%
Annual Report Gross Expense Ratio1.361.07127%
Fund Existence23 years11 years-
Gain YTD7.1507.31598%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets106B107B99%
Annual Yield % from dividends0.861.1674%
Returns for 1 year9.149.5096%
Returns for 3 years24.6625.8895%
Returns for 5 years60.1862.7196%
Returns for 10 years81.7974.51110%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VIR5.310.12
+2.31%
Vir Biotechnology
SPRO2.90N/A
N/A
Spero Therapeutics
AMED98.03-0.05
-0.05%
Amedisys
SHG44.16-0.24
-0.54%
Shinhan Financial Group Co Ltd
DFDV17.94-0.92
-4.88%
DeFi Development Corp